Robyn Karnauskas Stock Analyst Profile - Truist Securities Research Coverage - Stocknear

Robyn Karnauskas

Stock Analyst at Truist Securities

(3.7)
# 2442
Out of 5,477 analysts
218
Total ratings
Success rate
Average return
44 Stocks
Name Action PT Current % Upside Ratings Updated
TRML Tourmaline Bio
Downgrades: Hold
63 48
47.6 0.84% 3 Sep 10, 2025
ABCL AbCellera Biologics
Maintains: Buy
28 10
4.61 116.92% 2 May 16, 2025
AMGN Amgen
Maintains: Hold
333 298
282.73 5.4% 12 Jan 8, 2025
BMY Bristol-Myers Squibb
Maintains: Strong Buy
62 65
47.54 36.73% 2 Jan 8, 2025
MRK Merck & Co
Downgrades: Hold
130 110
85.16 29.17% 11 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1033 1029
755.95 36.12% 5 Oct 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Hold
82 83
117.86 -29.58% 15 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
195 210
220.19 -4.63% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jun 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
340 340
148.89 128.36% 17 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 26
1.82 1328.57% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 7
1.33 426.32% 13 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1135 1135
568.2 99.75% 16 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10
1.6 525% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
2.74 228.47% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23
14.41 59.61% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48
16.8 185.71% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50
11.5 334.78% 8 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
456 508
397.37 27.84% 12 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 36
24.85 44.87% 5 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
62.49 -53.59% 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
60.96 -58.99% 1 Oct 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140
55.91 150.4% 5 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
30000
n/a n/a 2 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
7
1.02 586.27% 3 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 55
16.94 224.68% 1 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 320
23.8 1244.54% 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 15
9.92 51.21% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 4
n/a n/a 2 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 10
25.59 -60.92% 5 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32
n/a n/a 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
580 120
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
3.41 633.14% 1 Nov 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
85
n/a n/a 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 165
n/a n/a 5 May 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
100 77
n/a n/a 6 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 44
n/a n/a 3 Aug 20, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 63
n/a n/a 3 Mar 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Feb 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
62 87
n/a n/a 1 Mar 2, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 8
n/a n/a 1 Mar 3, 2016